{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:07:01Z","timestamp":1784909221602,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s11655-023-3599-y","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T06:02:03Z","timestamp":1692424923000},"page":"222-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inflammatory and Immunomodulatory Effects of Tripterygium wilfordii Multiglycoside in Mouse Models of Psoriasis Keratinocytes"],"prefix":"10.1007","volume":"30","author":[{"given":"Shuo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-qi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-qiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,19]]},"reference":[{"key":"3599_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/ijd.15855","volume":"61","author":"Y Cao","year":"2022","unstructured":"Cao Y, Liang NN, Chang WJ, Li JQ, Jiao JJ, Hou RX, et al. Role of psoriatic keratinocytes in the metabolic reprogramming of dermal mesenchymal stem cells. Int J Dermatol 2022;61:337\u2013345.","journal-title":"Int J Dermatol"},{"key":"3599_CR2","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1007\/s00018-020-03726-1","volume":"78","author":"IS Afonina","year":"2021","unstructured":"Afonina IS, van Nuffel E, Beyaert R. Immune responses and therapeutic options in psoriasis. Cell Mol Life Sci 2021;78:2709\u20132727.","journal-title":"Cell Mol Life Sci"},{"key":"3599_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.joim.2019.01.004","volume":"17","author":"Y Yamakami","year":"2019","unstructured":"Yamakami Y, Morino K, Takauji Y, Kasukabe R, Miki K, Hossain MN, et al. Extract of Emblica officinalis enhances the growth of human keratinocytes in culture. J Integr Med 2019;17:141\u2013146.","journal-title":"J Integr Med"},{"key":"3599_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/2589977513666210707114520","volume":"14","author":"A Sharma","year":"2022","unstructured":"Sharma A, Upadhyay DK, Gupta GD, Narang RK, Rai VK. IL-23\/Th17 axis: a potential therapeutic target of psoriasis. Curr Drug Res Rev 2022;14:24\u201336.","journal-title":"Curr Drug Res Rev"},{"key":"3599_CR5","doi-asserted-by":"publisher","first-page":"102614","DOI":"10.1016\/j.jaut.2021.102614","volume":"118","author":"AK Srivastava","year":"2021","unstructured":"Srivastava AK, Yadav TC, Khera HK, Mishra P, Raghuwanshi N, Pruthi V, et al. Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities. J Autoimmun 2021;118:102614.","journal-title":"J Autoimmun"},{"key":"3599_CR6","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1002\/ptr.7155","volume":"35","author":"M Zhang","year":"2021","unstructured":"Zhang M, Li N, Cai R, Gu J, Xie F, Wei H, et al. Rosmarinic acid protects mice from imiquimod induced psoriasis-like skin lesions by inhibiting the IL-23\/Th17 axis via regulating JAK2\/ STAT3 signaling pathway. Phytother Res 2021;35:4526\u20134537.","journal-title":"Phytother Res"},{"key":"3599_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.17219\/acem\/112604","volume":"29","author":"JM Przepi\u00f3rka-Kosi\u0144ska","year":"2020","unstructured":"Przepi\u00f3rka-Kosi\u0144ska JM, Bartosi\u0144ska J, Raczkiewicz D, Bojar I, Kosi\u0144ski J, Krasowska D, et al. Serum concentration of osteopontin and interleukin 17 in psoriatic patients. Adv Clin Exp Med 2020;29:203\u2013208.","journal-title":"Adv Clin Exp Med"},{"key":"3599_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.autrev.2016.09.015","volume":"16","author":"LI Sakkas","year":"2017","unstructured":"Sakkas LI, Bogdanos DP. Are psoriasis and psoriatic arthritis the same disease? The IL-23\/IL-17 axis data. Autoimmun Rev 2017;16:10\u201315.","journal-title":"Autoimmun Rev"},{"key":"3599_CR9","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.4110\/in.2020.20.e6","volume":"20","author":"DS Kuen","year":"2020","unstructured":"Kuen DS, Kim BS, Chung Y. IL-17-producing cells in tumor immunity: friends or foes? Immune Netw 2020;20:e6.","journal-title":"Immune Netw"},{"key":"3599_CR10","doi-asserted-by":"publisher","first-page":"627139","DOI":"10.3389\/fimmu.2021.627139","volume":"12","author":"C Qi","year":"2021","unstructured":"Qi C, Wang Y, Li P, Zhao J. Gamma Delta T cells and their pathogenic role in psoriasis. Front Immunol 2021;12:627139.","journal-title":"Front Immunol"},{"key":"3599_CR11","doi-asserted-by":"publisher","first-page":"112644","DOI":"10.1016\/j.biopha.2022.112644","volume":"147","author":"L Liu","year":"2022","unstructured":"Liu L, Chen X, Lu Y, Sun XY, Ze K, Zhou YQ, et al. Celastrol gel ameliorates imiquimod-induced psoriasis-like dermatitis in mice by targeting Langerhans cells. Biomed Pharmacother 2022;147:112644.","journal-title":"Biomed Pharmacother"},{"key":"3599_CR12","doi-asserted-by":"publisher","first-page":"112283","DOI":"10.1016\/j.biopha.2021.112283","volume":"144","author":"S Wang","year":"2021","unstructured":"Wang S, Kozai M, Mita H, Cai Z, Masum MA, Ichii O, et al. REV-ERB agonist suppresses IL-17 production in \u03b3 \u03b4 T cells and improves psoriatic dermatitis in a mouse model. Biomed Pharmacother 2021;144:112283.","journal-title":"Biomed Pharmacother"},{"key":"3599_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1631\/jzus.B1900607","volume":"21","author":"CY Song","year":"2020","unstructured":"Song CY, Xu YG, Lu YQ. Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects. J Zhejiang Univ Sci B 2020;21:280\u2013290.","journal-title":"J Zhejiang Univ Sci B"},{"key":"3599_CR14","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3389\/fphar.2019.01469","volume":"10","author":"K Yuan","year":"2019","unstructured":"Yuan K, Li X, Lu Q, Zhu Q, Jiang H, Wang T, et al. Application and mechanisms of triptolide in the treatment of inflammatory diseases\u2014a review. Front Pharmacol 2019;10:1469.","journal-title":"Front Pharmacol"},{"key":"3599_CR15","first-page":"98","volume":"28","author":"J Li","year":"2019","unstructured":"Li J, Zhang T, Fei XF, Song Y. Application of Tripterygium wilfordii in the treatment of psoriasis. China Pharmaceutic (Chin) 2019;28:98\u2013101.","journal-title":"China Pharmaceutic (Chin)"},{"key":"3599_CR16","doi-asserted-by":"publisher","first-page":"583171","DOI":"10.3389\/fphar.2020.583171","volume":"11","author":"Y Tang","year":"2020","unstructured":"Tang Y, Liu Q, Feng Y, Zhang Y, Xu Z, Wen C, et al. Tripterygium ingredients for pathogenicity cells in rheumatoid arthritis. Front Pharmacol 2020;11:583171.","journal-title":"Front Pharmacol"},{"key":"3599_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s11684-018-0649-5","volume":"13","author":"D Luo","year":"2019","unstructured":"Luo D, Zuo Z, Zhao H, Tan Y, Xiao C. Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice. Front Med 2019;13:556\u2013563.","journal-title":"Front Med"},{"key":"3599_CR18","doi-asserted-by":"publisher","first-page":"109993","DOI":"10.1016\/j.intimp.2023.109993","volume":"118","author":"Y Xie","year":"2023","unstructured":"Xie Y, Ding J, Gao J, Zhang J, Cen S, Zhou J. Triptolide reduces PD-L1 through the EGFR and IFN-\u03b3\/IRF1 dual signaling pathways. Int Immunopharmacol 2023;118:109993.","journal-title":"Int Immunopharmacol"},{"key":"3599_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13020-021-00525-z","volume":"16","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Zhao Y, Zheng Y. Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity. Chin Med 2021;16:114.","journal-title":"Chin Med"},{"key":"3599_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/13880209.2019.1634106","volume":"57","author":"JM Wang","year":"2019","unstructured":"Wang JM, Li JY, Cai H, Chen RX, Zhang YY, Zhang LL, et al. Nrf2 participates in mechanisms for reducing the toxicity and enhancing the antitumour effect of Radix Tripterygium wilfordii to S180-bearing mice by herbal-processing technology. Pharm Biol 2019;57:437\u2013448.","journal-title":"Pharm Biol"},{"key":"3599_CR21","doi-asserted-by":"publisher","first-page":"L958","DOI":"10.1152\/ajplung.2000.279.5.L958","volume":"279","author":"GH Zhao","year":"2000","unstructured":"Zhao GH, Vaszar LT, Qiu DM, Shi LF, Kao PN. Antiinflammatory effects of triptolide in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2000;279:L958\u2013L966.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3599_CR22","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1016\/j.xphs.2022.06.005","volume":"111","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Kuo JC, Zhang C, Huang Y, Lee RJ. Ivermectin enhanced antitumor activity of Resiquimod in a co-loaded squalene emulsion. J Pharm Sci 2022;111:3038\u20133046.","journal-title":"J Pharm Sci"},{"key":"3599_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bbrc.2017.02.021","volume":"485","author":"R Li","year":"2017","unstructured":"Li R, Lu K, Wang Y, Chen M, Zhang F, Shen H, et al. Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression. Biochem Biophys Res Commun 2017;485:69\u201375.","journal-title":"Biochem Biophys Res Commun"},{"key":"3599_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40659-020-00316-0","volume":"53","author":"J Gao","year":"2020","unstructured":"Gao J, Chen F, Fang H, Mi J, Qi Q, Yang M. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Biol Res 2020;53:48.","journal-title":"Biol Res"},{"key":"3599_CR25","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","volume":"139","author":"S Moos","year":"2019","unstructured":"Moos S, Mohebiany AN, Waisman A, Kurschus FC. Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes. J Invest Dermatol 2019;139:1110\u20131117.","journal-title":"J Invest Dermatol"},{"key":"3599_CR26","first-page":"3","volume":"37","author":"HQ Liao","year":"2021","unstructured":"Liao HQ, Yang B. Effects of Tripterygium wilfordii polyglycosides on imiquimod induced psoriasis like lesions in mice and its mechanism. Chin J Clin Pharmacol (Chin) 2021;37:3.","journal-title":"Chin J Clin Pharmacol (Chin)"},{"key":"3599_CR27","doi-asserted-by":"publisher","first-page":"153864","DOI":"10.1016\/j.phymed.2021.153864","volume":"95","author":"J Guo","year":"2022","unstructured":"Guo J, Qi C, Liu Y, Guo X, Meng Y, Zhao J, et al. Terrestrosin D ameliorates skin lesions in an imiquimod-induced psoriasis-like murine model by inhibiting the interaction between substance P and dendritic cells. Phytomedicine 2022;95:153864.","journal-title":"Phytomedicine"},{"key":"3599_CR28","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.2147\/DDDT.S254466","volume":"14","author":"Q He","year":"2020","unstructured":"He Q, Zhang B, Hu F, Long J, Shi Q, Pi X, et al. Triptolide inhibits the proliferation of HaCaT cells induced by IL22 via upregulating miR-181b-5p. Drug Des Devel Ther 2020;14:2927\u20132935.","journal-title":"Drug Des Devel Ther"},{"key":"3599_CR29","first-page":"97","volume":"93","author":"F Gr\u00e4n","year":"2020","unstructured":"Gr\u00e4n F, Kerstan A, Serfling E, Goebeler M, Muhammad K. Current developments in the immunology of psoriasis. Yale J Biol Med 2020;93:97\u2013110.","journal-title":"Yale J Biol Med"},{"key":"3599_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cyto.2014.11.020","volume":"74","author":"B Astry","year":"2015","unstructured":"Astry B, Venkatesha SH, Moudgil KD. Involvement of the IL-23\/IL-17 axis and the Th17\/Treg balance in the pathogenesis and control of autoimmune arthritis. Cytokine 2015;74:54\u201361.","journal-title":"Cytokine"},{"key":"3599_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s40257-022-00686-z","volume":"23","author":"M Yamanaka-Takaichi","year":"2022","unstructured":"Yamanaka-Takaichi M, Ghanian S, Katzka DA, Torgerson RR, Alavi A. Candida infection associated with anti-IL-17 medication: a systematic analysis and review of the literature. Am J Clin Dermatol 2022;23:469\u2013480.","journal-title":"Am J Clin Dermatol"},{"key":"3599_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/exd.13481","volume":"27","author":"HJ Kim","year":"2018","unstructured":"Kim HJ, Kim SH, Kim TG, Park JY, Lee M, Kim DS, et al. Interleukin-21 receptor signalling is not critically required for imiquimod-induced psoriasiform dermatitis in mice. Exp Dermatol 2018;27:191\u2013195.","journal-title":"Exp Dermatol"},{"key":"3599_CR33","doi-asserted-by":"publisher","first-page":"13839","DOI":"10.1038\/ncomms13839","volume":"7","author":"F Li","year":"2017","unstructured":"Li F, Hao X, Chen Y, Bai L, Gao X, Lian Z, et al. The microbiota maintain homeostasis of liver-resident \u03b3 \u03b4 T-17 cells in a lipid antigen\/CD1d-dependent manner. Nat Commun 2017;7:13839.","journal-title":"Nat Commun"},{"key":"3599_CR34","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.3390\/ijms20102558","volume":"20","author":"TH Huang","year":"2019","unstructured":"Huang TH, Lin CF, Alalaiwe A, Yang SC, Fang JY. Apoptotic or antiproliferative activity of natural products against keratinocytes for the treatment of psoriasis. Int J Mol Sci 2019;20:2558.","journal-title":"Int J Mol Sci"},{"key":"3599_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/BOR.0000000000000232","volume":"28","author":"A Paine","year":"2016","unstructured":"Paine A, Ritchlin C. Bone remodeling in psoriasis and psoriatic arthritis: an update. Curr Opin Rheumatol 2016;28:66\u201375.","journal-title":"Curr Opin Rheumatol"},{"key":"3599_CR36","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/cmi.2016.53","volume":"14","author":"H Bai","year":"2017","unstructured":"Bai H, Gao X, Zhao L, Peng Y, Yang J, Qiao S, et al. Respective IL-17A production by \u03b3 \u03b4 T and Th17 cells and its implication in host defense against chlamydial lung infection. Cell Mol Immunol 2017;14:850\u2013861.","journal-title":"Cell Mol Immunol"},{"key":"3599_CR37","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jaci.2018.01.054","volume":"142","author":"Y Ueharaguchi","year":"2018","unstructured":"Ueharaguchi Y, Honda T, Kusuba N, Hanakawa S, Adachi A, Sawada Y, et al. Thromboxane A2 facilitates IL-17A production from V\u03b34+ \u03b3 \u03b4 T cells and promotes psoriatic dermatitis in mice. J Allergy Clin Immunol 2018;142:680\u2013683.e2.","journal-title":"J Allergy Clin Immunol"},{"key":"3599_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","volume":"139","author":"Y Cai","year":"2019","unstructured":"Cai Y, Xue F, Quan C, Qu M, Liu N, Zhang Y, et al. A critical role of the IL-1\u03b2 -IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis. J Invest Dermatol 2019;139:146\u2013156.","journal-title":"J Invest Dermatol"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-023-3599-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-023-3599-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-023-3599-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T05:30:56Z","timestamp":1708666256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-023-3599-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,19]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3599"],"URL":"https:\/\/doi.org\/10.1007\/s11655-023-3599-y","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,19]]},"assertion":[{"value":"9 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}